CoChat

Genetic Deletion of the p66 Shc Adaptor Protein Protects From Angiotensin II–Induced Myocardial Damage

Graiani, Gallia, Lagrasta, Costanza, Migliaccio, Enrica, Spillmann, Frank, Meloni, Marco, Madeddu, Paolo, Quaini, Federico, Padura, Ines Martin, Lanfrancone, Luisa, Pelicci, PierGiuseppe, Emanueli, Costanza · 2005 · Hypertension
Cited by 110

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Angiotensin II (Ang II), acting through its G protein–coupled AT 1 receptor (AT 1 ), contributes to the precocious heart senescence typical of patients with hypertension, atherosclerosis, and diabetes. AT 1 was suggested to transactivate an intracellular signaling controlled by growth factors and their tyrosin-kinase receptors. In cultured vascular smooth muscle cells, this downstream mechanism comprises the p66 Shc adaptor protein, previously recognized to play a role in vascular cell senescence and death. The aim of the present study was 2-fold: (1) to characterize the cardiovascular phenotype of p66 Shc knockout mice ( p66 Shc −/− ), and (2) to test the novel hypothesis that disrupting the p66 Shc might protect the heart from the damaging action of elevated Ang II levels. Compared with wild-type littermates ( p66 Shc +/+ ), p66 Shc −/− showed similar blood pressure, heart rate, and left ventricular wall thickness. However, cardiomyocyte number was increased in mutant animals, indicating a condition of myocardial hyperplasia. In p66 Shc +/+ , infusion of a sub-pressor dose of Ang II (300 nmol/kg body weight [BW] daily for 28 days) caused left ventricular hypertrophy and apoptotic death of cardiomyocytes and endothelial cells. In contrast, p66 Shc −/− were resistant to the proapoptotic/hypertrophic action of Ang II. Consistently, in vitro experiments showed that Ang II causes apoptotic death of cardiomyocytes isolated from p66 Shc +/+ hearts to a greater extent as compared with p66 Shc −/− cardiomyocytes. Our results indicate a fundamental role of p66 Shc in Ang II–mediated myocardial remodeling. In perspective, p66 Shc inhibition may be envisioned as a novel way to prevent the deleterious effects of Ang II on the heart.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000174986.73346.ba

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 110

Metadata

Authors
Graiani, G., Lagrasta, C., Migliaccio, E., Spillmann, F., Meloni, M., Madeddu, P., Quaini, F., Padura, I. M., Lanfrancone, L., Pelicci, P., & Emanueli, C.
Venue
Hypertension
Published
2005-08
Volume
46
Issue
2
Pages
433-440
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2131358181
Cited by
110
References
3
FWCI
5.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Deletion of the p66 Shc Adaptor Protein Protects From Angiotensin II–Induced Myocardial Damage. https://app.cochat.ai/papers/10.1161/01.hyp.0000174986.73346.ba
The paper
Graiani, G., Lagrasta, C., Migliaccio, E., Spillmann, F., Meloni, M., Madeddu, P., Quaini, F., Padura, I. M., Lanfrancone, L., Pelicci, P., & Emanueli, C. (2005). Genetic Deletion of the p66 Shc Adaptor Protein Protects From Angiotensin II–Induced Myocardial Damage. Hypertension. https://doi.org/10.1161/01.hyp.0000174986.73346.ba

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.